Hayat Pharmaceutical Industries Co (AMM:HPIC) Market Cap: JOD29.74 Mil (As of Jun. 30, 2026)


AMM:HPIC Hayat Pharmaceutical Industries Co AMM:HPIC
76 GF Score
Price JOD3.13
GF Value JOD2.74
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Hayat Pharmaceutical Industries Co Market Cap?

Hayat Pharmaceutical Industries Co AMM:HPIC 76 Market Cap is JOD29.74 Mil as of Jun. 30, 2026. GuruFocus rates AMM:HPIC with a GF Score™ of 76/100 and a GF Value™ of JOD2.74 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 1,020 Drug Manufacturers companies, Hayat Pharmaceutical Industries Co ranks worse than 70.39% on this metric.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Hayat Pharmaceutical Industries Co's share price for the quarter that ended in Mar. 2026 was JOD3.21. Hayat Pharmaceutical Industries Co's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 9.50 Mil. Therefore, Hayat Pharmaceutical Industries Co's market cap for the quarter that ended in Mar. 2026 was JOD30.50 Mil.

Hayat Pharmaceutical Industries Co's quarterly market cap increased from Sep. 2025 (JOD28.03 Mil) to Dec. 2025 (JOD31.35 Mil) but then declined from Dec. 2025 (JOD31.35 Mil) to Mar. 2026 (JOD30.50 Mil).

Hayat Pharmaceutical Industries Co's annual market cap increased from Dec. 2023 (JOD22.80 Mil) to Dec. 2024 (JOD23.28 Mil) and increased from Dec. 2024 (JOD23.28 Mil) to Dec. 2025 (JOD31.35 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Hayat Pharmaceutical Industries Co's Enterprise Value for Today is JOD23.75 Mil.


Hayat Pharmaceutical Industries Co  (AMM:HPIC) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Hayat Pharmaceutical Industries Co Market Cap Related Terms


Hayat Pharmaceutical Industries Co Market Cap Historical Data

* Premium members only.

The historical data trend for Hayat Pharmaceutical Industries Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hayat Pharmaceutical Industries Co Market Cap Chart

Hayat Pharmaceutical Industries Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 36.01 28.03 22.80 23.28 31.35

Hayat Pharmaceutical Industries Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.31 28.41 28.03 31.35 30.50

AMM:HPIC vs ZTS, UTHR, VTRS: Market Cap Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Hayat Pharmaceutical Industries Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hayat Pharmaceutical Industries Co Market Cap vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hayat Pharmaceutical Industries Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Hayat Pharmaceutical Industries Co's Market Cap falls into.


AMM:HPIC
76GF Score
Hayat Pharmaceutical Industries Co AMM:HPIC
Market Cap is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hayat Pharmaceutical Industries Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Hayat Pharmaceutical Industries Co's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as

Market Cap (A: Dec. 2025 )=Share Price (A: Dec. 2025 )*Shares Outstanding (EOP) (A: Dec. 2025 )
=JOD3.3*9.500
=JOD31.35

Hayat Pharmaceutical Industries Co's Market Cap for the quarter that ended in Mar. 2026 is calculated as

Market Cap (Q: Mar. 2026 )=Share Price (Q: Mar. 2026 )*Shares Outstanding (EOP) (Q: Mar. 2026 )
=JOD3.21*9.500
=JOD30.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of JOD29.74 Mil mean?
Hayat Pharmaceutical Industries Co (AMM:HPIC) has a Market Cap of JOD29.74 Mil as of Jun. 30, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Hayat Pharmaceutical Industries Co and its competitors. According to the industry distribution chart, Hayat Pharmaceutical Industries Co ranks #718 out of 1020 companies in the Drug Manufacturers industry, placing it in the top 70.4%.
Is Hayat Pharmaceutical Industries Co's Market Cap too high?
Hayat Pharmaceutical Industries Co's current Market Cap is JOD29.74 Mil. Based on the distribution chart, Hayat Pharmaceutical Industries Co ranks #718 out of 1020 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Hayat Pharmaceutical Industries Co has a GF Score™ of 76/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hayat Pharmaceutical Industries Co's Market Cap compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Hayat Pharmaceutical Industries Co ranks #718 out of 1020 companies for Market Cap. This places Hayat Pharmaceutical Industries Co in the lower half of its industry. The industry median Market Cap is 213.67. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 213.67, based on 1,020 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Hayat Pharmaceutical Industries Co and its competitors. For the Drug Manufacturers industry, the median Market Cap is 213.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hayat Pharmaceutical Industries Co's current Market Cap is JOD29.74 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hayat Pharmaceutical Industries Co stock overvalued right now?
Based on GuruFocus' analysis, Hayat Pharmaceutical Industries Co (AMM:HPIC) is currently considered Modestly Overvalued. The stock's GF Value™ is JOD2.74, compared to a current price of JOD3.13 — trading 14.2% above its estimated fair value. The current Market Cap is JOD29.74 Mil. Hayat Pharmaceutical Industries Co's overall GF Score™ is 76/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Hayat Pharmaceutical Industries Co (AMM:HPIC), the current Market Cap is JOD29.74 Mil as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hayat Pharmaceutical Industries Co (AMM:HPIC) Overvalued in 2026?

Based on GuruFocus' analysis, Hayat Pharmaceutical Industries Co stock appears to be overvalued. The current stock price of JOD3.13 is trading 14.2% above its estimated GF Value™ of JOD2.74. GuruFocus considers Hayat Pharmaceutical Industries Co to be Modestly Overvalued.

Key valuation signals for AMM:HPIC:

  • Market Cap: JOD29.74 Mil
  • GF Value™: JOD2.74 vs. price of JOD3.13 (14.2% above fair value)
  • GF Score™: 76/100 with 6 warning signs

No single metric tells the full story. See the AMM:HPIC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Hayat Pharmaceutical Industries Co Business Description

Address Mohammed Ali Alkurdi St. Al-Rajeeb Amman, 1564 Amman, Amman, JOR, 11118
Hayat Pharmaceutical Industries Co is a Jordan based pharmaceutical manufacturing company. The princapal activity is producing human and veterinary medicines in all its forms and medical stickers and stockings, in addition to the production of medical supplies, body care lotions, cosmetics, sutures and initiating marketing campgains as well as import and export operations. Its products include Cardiovascular system, Infectious disease, Dermatology, Gastrointestinal system, Inner Ear & Balance, Men's Health, Neurology, Vitamins & Supplements, Women's Health, and Respiratory system. The operations business operating within one geographic sector which is the Hashemite Kingdom of Jordan.
76GF Score

Get the complete analysis for AMM:HPIC

Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

JOD3.13
Price
JOD2.74
GF Value